US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 1.3700
  • +0.0200+1.48%
Close Apr 18 16:00 ET
6.08MMarket Cap-1191P/E (TTM)

About Protagenic Therapeutics Company

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Company Profile

SymbolPTIX
Company NameProtagenic Therapeutics
Listing DateApr 27, 2021
Issue Price4.50
Founded1994
CEODr. Garo H. Armen, Pd.D
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address149 Fifth Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8200
Websitehttp://www.protagenic.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert B. Stein, M.D.,PhD
  • Director and Chief Medical Officer
  • --
  • Dr. Alexander K. Arrow, M.D.
  • Chief Financial Officer
  • 150.00K
  • Andrew Slee
  • Chief Operating Officer
  • --
  • Dr. Garo H. Armen, Pd.D
  • Executive Chairman of the Board and Principal Executive Officer
  • --
  • Dr. Jennifer S. Buell, PhD
  • Director
  • --
  • Brian J. Corvese
  • Independent Director
  • --
  • Khalil Barrage
  • Independent Director
  • --
  • Timothy R. Wright
  • Lead Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg